BiommBSP:BIOM3 +1.81%51 Gross Margin % is 36.62% as of Mar. 2026, which is 86% above its 10-year median of 19.68. GuruFocus rates BSP:BIOM3 with a GF Score™ of 51/100 and a GF Value™ of R$15.96 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 732 Biotechnology companies, Biomm ranks worse than 73.5% on this metric.
Gross Margin % is calculated as gross profit divided by its revenue. Biomm's Gross Profit for the
three
months ended in Mar. 2026 was R$33.9 Mil. Biomm's Revenue for the
three
months ended in Mar. 2026 was R$92.5 Mil. Therefore, Biomm's Gross Margin % for the quarter that ended in Mar. 2026 was 36.62%.
Warning Sign:
Biomm SA gross margin has been in long-term decline. The average rate of decline per year is -1.2%.
The historical rank and industry rank for Biomm's Gross Margin % or its related term are showing as below:
BSP:BIOM3'
s Gross Margin % Range Over the Past 10 Years
Min: 5.83 Med: 19.68 Max: 34.95
Current: 34.61
During the past 13 years, the highestGross Margin % of Biomm was 34.95%. The lowest was 5.83%. And the median was 19.68%.
BSP:BIOM3's Gross Margin % is ranked worse than 73.5% of 732
companies
in the Biotechnology industry
Industry Median: 60.905
vs BSP:BIOM3: 34.61
Biomm had a gross margin of 36.62% for the quarter that ended in Mar. 2026 => Competition eroding margins
The 5-Year average Growth Rate of Gross Margin for Biomm was -1.20% per year.
Biomm (BSP:BIOM3) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Biomm had a gross margin of 36.62% for the quarter that ended in Mar. 2026 => Competition eroding margins
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Biomm Gross Margin % Related Terms
Biomm Gross Margin % Historical Data
* Premium members only.
The historical data trend for Biomm's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BSP:BIOM3 vs VRTX, REGN, ALNY: Gross Margin % Comparison
For the Biotechnology subindustry, Biomm's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Biomm Gross Margin % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Biomm's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Biomm's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Biomm (BSP:BIOM3) has a Gross Margin % of 36.62% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Biomm and its competitors. This is 86% above median its historical median of 19.68. Over the past decade, Biomm's Gross Margin % has ranged from 5.83 to 34.95. According to the industry distribution chart, Biomm ranks #538 out of 732 companies in the Biotechnology industry, placing it in the top 73.5%.
Is Biomm's Gross Margin % too high?
Biomm's current Gross Margin % of 36.62% is 86% above median its 10-year median of 19.68. Over the past 10 years, this metric has ranged from a low of 5.83 to a high of 34.95. The Biotechnology industry median Gross Margin % is 60.91. Biomm's value of 36.62% is 39.9% below this industry median. Based on the distribution chart, Biomm ranks #538 out of 732 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Biomm has a GF Score™ of 51/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Biomm's Gross Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Biomm ranks #538 out of 732 companies for Gross Margin %. This places Biomm in the lower half of its industry. The industry median Gross Margin % is 60.91. Biomm's value of 36.62% is 39.9% below this benchmark. Historically, Biomm's own Gross Margin % has ranged from 5.83 to 34.95 over the past decade. While the company's 10-year median is 19.68 vs. the industry median of 60.91, Biomm has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Biotechnology company?
The median Gross Margin % among Biotechnology companies is 60.91, based on 732 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Biomm's current Gross Margin % of 36.62% is 39.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Biomm and its competitors. For the Biotechnology industry, the median Gross Margin % is 60.91 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Biomm's current Gross Margin % is 36.62%, which is 86% above median its own 10-year median of 19.68. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biomm stock overvalued right now?
Based on GuruFocus' analysis, Biomm (BSP:BIOM3) is currently considered Possible Value Trap. The stock's GF Value™ is R$15.96, compared to a current price of R$6.20 — trading 61.2% below its estimated fair value. The current Gross Margin % is 36.62%, which is 86% above median its 10-year median of 19.68 and 39.9% below the Biotechnology industry median of 60.91. Biomm's overall GF Score™ is 51/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Biomm (BSP:BIOM3), the current Gross Margin % is 36.62% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Biomm (BSP:BIOM3) Overvalued in 2026?
Based on GuruFocus' analysis, Biomm stock appears to be undervalued.
The current stock price of R$6.20 is trading 61.2% below its estimated GF Value™ of R$15.96.
GuruFocus considers Biomm to be Possible Value Trap.
Key valuation signals for BSP:BIOM3:
Gross Margin %: 36.62% (86% above median its 10-year median of 19.68)
GF Value™: R$15.96 vs. price of R$6.20 (61.2% below fair value)
Industry Position: 39.9% below the Biotechnology median (#538 of 732)
No single metric tells the full story. See the BSP:BIOM3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Biomm SA is engaged in biotechnological processes for the production of active pharmaceutical ingredients and other industrial purposes, such as enzymes used in the production of Biofuels.The Company is patented for insulin production.The company develops processes for the production of insulin and other biotech products, as well as processes for other industrial applications, such as enzymes that are used in the production of biofuels.
51GF Score
Get the complete analysis for BSP:BIOM3
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BSP:BIOM3 has been successfully added to your 
